secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEANOMICS, INC. (—)
CIK:        0000837852
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001104659-22-124087
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ideanomics receives Nasdaq notice for audit committee non-compliance; cure period through Oct 2023
--------------------------------------------------------------------------------

- Nasdaq notified Ideanomics on Nov 30, 2022 that its Audit Committee has only 2 independent directors, violating Listing Rule 5605.
- Cure period ends at earlier of next annual meeting or Oct 31, 2023; if meeting before May 1, 2023, then by May 1, 2023.
- Company plans to appoint an additional independent director to the Board and Audit Committee as soon as practicable.
- The deficiency has no immediate effect on listing or trading of IDEX common stock on the Nasdaq Capital Market.
- There is no assurance the Company will regain compliance or maintain other listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/837852/000110465922124087/0001104659-22-124087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/837852/000110465922124087/tm2231772d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-124087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer